Treatment of cancer
AssigneeVirttu Biologics Limited
InventorsJoe CONNER, Timothy CRIPE
Life of this patent
Estimating the term…
Abstract
A method of treating cancer in a subject is disclosed, the method comprising administration of an oncolytic herpes simplex virus and administration of lymphocyte cells modified to express a chimeric antigen receptor (CAR) or modified to express a T cell receptor (TCR).
Claims17
A method of treating cancer in a subject, the method comprising administration of an oncolytic herpes simplex virus and administration of human lymphocyte cells modified to express a chimeric antigen receptor (CAR) or modified to express a T cell receptor (TCR).
A method of increasing the efficacy of adoptive cell therapy in a subject by administering an oncolytic herpes simplex virus to a subject in need thereof.
A kit comprising at least one container having a predetermined quantity of oncolytic herpes simplex virus, and at least one container having a predetermined quantity of human lymphocytes modified to express a chimeric antigen receptor (CAR) or T cell receptor (TCR).
Dependencies are inferred from the claim text.